Loading...

Vitali Moiseenko

TitleProfessor Of Clinical
InstitutionUniversity of California San Diego
DepartmentRadiation Medicine and Applied Science
Address9500 Gilman Drive #0865
La Jolla CA 92093
Phone858-534-3537
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Kaderka R, Gillespie EF, Mundt RC, Bryant AK, Sanudo-Thomas CB, Harrison AL, Wouters EL, Moiseenko V, Moore KL, Atwood TF, Murphy JD. Geometric and dosimetric evaluation of atlas based auto-segmentation of cardiac structures in breast cancer patients. Radiother Oncol. 2018 Aug 11. PMID: 30107948.
      View in: PubMed
    2. Lloyd SAM, Lim TY, Fave X, Flores-Martinez E, Atwood TF, Moiseenko V. TG-51 reference dosimetry for the Halcyon™: A clinical experience. J Appl Clin Med Phys. 2018 May 21. PMID: 29785729.
      View in: PubMed
    3. Thor M, Jackson A, Zelefsky MJ, Steineck G, Karlsdòttir A, Høyer M, Liu M, Nasser NJ, Petersen SE, Moiseenko V, Deasy JO. Inter-institutional analysis demonstrates the importance of lower than previously anticipated dose regions to prevent late rectal bleeding following prostate radiotherapy. Radiother Oncol. 2018 Apr; 127(1):88-95. PMID: 29530433.
      View in: PubMed
    4. Murzin VL, Woods K, Moiseenko V, Karunamuni R, Tringale KR, Seibert TM, Connor MJ, Simpson DR, Sheng K, Hattangadi-Gluth JA. 4p plan optimization for cortical-sparing brain radiotherapy. Radiother Oncol. 2018 Apr; 127(1):128-135. PMID: 29519628.
      View in: PubMed
    5. Milano MT, Grimm J, Soltys SG, Yorke E, Moiseenko V, Tomé WA, Sahgal A, Xue J, Ma L, Solberg TD, Kirkpatrick JP, Constine LS, Flickinger JC, Marks LB, El Naqa I. Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways. Int J Radiat Oncol Biol Phys. 2018 Jan 31. PMID: 29534899.
      View in: PubMed
    6. Vargo JA, Moiseenko V, Grimm J, Caudell J, Clump DA, Yorke E, Xue J, Vinogradskiy Y, Moros EG, Mavroidis P, Jain S, El Naqa I, Marks LB, Heron DE. Head and Neck Tumor Control Probability: Radiation Dose-Volume Effects in Stereotactic Body Radiation Therapy for Locally Recurrent Previously-Irradiated Head and Neck Cancer: Report of the AAPM Working Group. Int J Radiat Oncol Biol Phys. 2018 Jan 31. PMID: 29477291.
      View in: PubMed
    7. Miften M, Vinogradskiy Y, Moiseenko V, Grimm J, Yorke E, Jackson A, Tomé WA, Ten Haken RK, Ohri N, Méndez Romero A, Goodman KA, Marks LB, Kavanagh B, Dawson LA. Radiation Dose-Volume Effects for Liver SBRT. Int J Radiat Oncol Biol Phys. 2018 Jan 06. PMID: 29482870.
      View in: PubMed
    8. Casares-Magaz O, Muren LP, Moiseenko V, Petersen SE, Pettersson NJ, Høyer M, Deasy JO, Thor M. Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer. Acta Oncol. 2017 Nov; 56(11):1507-1513. PMID: 28885095.
      View in: PubMed
    9. Cerviño L, Soultan D, Cornell M, Yock A, Pettersson N, Song WY, Aguilera J, Advani S, Murphy J, Hoh C, James C, Paravati A, Coope R, Gill B, Moiseenko V. A novel 3D-printed phantom insert for 4D PET/CT imaging and simultaneous integrated boost radiotherapy. Med Phys. 2017 Oct; 44(10):5467-5474. PMID: 28766726.
      View in: PubMed
    10. Connor M, Karunamuni R, McDonald C, Seibert T, White N, Moiseenko V, Bartsch H, Farid N, Kuperman J, Krishnan A, Dale A, Hattangadi-Gluth JA. Regional susceptibility to dose-dependent white matter damage after brain radiotherapy. Radiother Oncol. 2017 05; 123(2):209-217. PMID: 28460824.
      View in: PubMed
    11. Casares-Magaz O, Moiseenko V, Hopper A, Pettersson NJ, Thor M, Knopp R, Deasy JO, Muren LP, Einck J. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer. Acta Oncol. 2017 Jun; 56(6):884-890. PMID: 28401808.
      View in: PubMed
    12. Karunamuni RA, White NS, McDonald CR, Connor M, Pettersson N, Seibert TM, Kuperman J, Farid N, Moiseenko V, Dale AM, Hattangadi-Gluth JA. Multi-component diffusion characterization of radiation-induced white matter damage. Med Phys. 2017 May; 44(5):1747-1754. PMID: 28222217.
      View in: PubMed
    13. Connor MJ, Tringale K, Moiseenko V, Marshall DC, Moore K, Cervino L, Atwood T, Brown D, Mundt AJ, Pawlicki T, Recht A, Hattangadi-Gluth JA. Medical Device Recalls in Radiation Oncology: Analysis of US Food and Drug Administration Data, 2002-2015. Int J Radiat Oncol Biol Phys. 2017 06 01; 98(2):438-446. PMID: 28463163.
      View in: PubMed
    14. Seibert TM, Karunamuni R, Kaifi S, Burkeen J, Connor M, Krishnan AP, White NS, Farid N, Bartsch H, Murzin V, Nguyen TT, Moiseenko V, Brewer JB, McDonald CR, Dale AM, Hattangadi-Gluth JA. Cerebral Cortex Regions Selectively Vulnerable to Radiation Dose-Dependent Atrophy. Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):910-918. PMID: 28333012.
      View in: PubMed
    15. Connor MJ, Marshall DC, Moiseenko V, Moore K, Cervino L, Atwood T, Sanghvi P, Mundt AJ, Pawlicki T, Recht A, Hattangadi-Gluth JA. Adverse Events Involving Radiation Oncology Medical Devices: Comprehensive Analysis of US Food and Drug Administration Data, 1991 to 2015. Int J Radiat Oncol Biol Phys. 2017 01 01; 97(1):18-26. PMID: 27979446.
      View in: PubMed
    16. Gillespie EF, Panjwani N, Golden DW, Gunther J, Chapman TR, Brower JV, Kosztyla R, Larson G, Neppala P, Moiseenko V, Bykowski J, Sanghvi P, Murphy JD. Multi-institutional Randomized Trial Testing the Utility of an Interactive Three-dimensional Contouring Atlas Among Radiation Oncology Residents. Int J Radiat Oncol Biol Phys. 2017 07 01; 98(3):547-554. PMID: 28262474.
      View in: PubMed
    17. Thor M, Owosho AA, Clark HD, Oh JH, Riaz N, Hovan A, Tsai J, Thomas SD, Yom SHK, Wu JS, Huryn JM, Moiseenko V, Lee NY, Estilo CL, Deasy JO. Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer. Radiother Oncol. 2017 02; 122(2):200-206. PMID: 27890427.
      View in: PubMed
    18. Seibert TM, Karunamuni R, Bartsch H, Kaifi S, Krishnan AP, Dalia Y, Burkeen J, Murzin V, Moiseenko V, Kuperman J, White NS, Brewer JB, Farid N, McDonald CR, Hattangadi-Gluth JA. Radiation Dose-Dependent Hippocampal Atrophy Detected With Longitudinal Volumetric Magnetic Resonance Imaging. Int J Radiat Oncol Biol Phys. 2017 02 01; 97(2):263-269. PMID: 28068234.
      View in: PubMed
    19. Connor M, Karunamuni R, McDonald C, White N, Pettersson N, Moiseenko V, Seibert T, Marshall D, Cervino L, Bartsch H, Kuperman J, Murzin V, Krishnan A, Farid N, Dale A, Hattangadi-Gluth J. Dose-dependent white matter damage after brain radiotherapy. Radiother Oncol. 2016 11; 121(2):209-216. PMID: 27776747.
      View in: PubMed
    20. Moiseenko V, Einck J, Murphy J, Ödén J, Bjöhle J, Uzan J, Gagliardi G. Clinical evaluation of QUANTEC guidelines to predict the risk of cardiac mortality in breast cancer patients. Acta Oncol. 2016 Dec; 55(12):1506-1510. PMID: 27732122.
      View in: PubMed
    21. Kosztyla R, Reinsberg SA, Moiseenko V, Toyota B, Nichol A. Interhemispheric Difference Images from Postoperative Diffusion Tensor Imaging of Gliomas. Cureus. 2016 Oct 05; 8(10):e817. PMID: 27843735.
      View in: PubMed
    22. Seibert TM, White NS, Kim GY, Moiseenko V, McDonald CR, Farid N, Bartsch H, Kuperman J, Karunamuni R, Marshall D, Holland D, Sanghvi P, Simpson DR, Mundt AJ, Dale AM, Hattangadi-Gluth JA. Distortion inherent to magnetic resonance imaging can lead to geometric miss in radiosurgery planning. Pract Radiat Oncol. 2016 Nov - Dec; 6(6):e319-e328. PMID: 27523440.
      View in: PubMed
    23. Moiseenko V, Khvostunov IK, Hattangadi-Gluth JA, Muren LP, Lloyd DC. Biological dosimetry to assess risks of health effects in victims of radiation accidents: Thirty years after Chernobyl. Radiother Oncol. 2016 04; 119(1):1-4. PMID: 26970677.
      View in: PubMed
    24. Karunamuni RA, Moore KL, Seibert TM, Li N, White NS, Bartsch H, Carmona R, Marshall D, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell LK, Brewer J, Dale AM, Moiseenko V, Hattangadi-Gluth JA. Radiation sparing of cerebral cortex in brain tumor patients using quantitative neuroimaging. Radiother Oncol. 2016 Jan; 118(1):29-34. PMID: 26806266.
      View in: PubMed
    25. Kimsey F, McKay J, Gefter J, Milano MT, Moiseenko V, Grimm J, Berg R. Dose-Response Model for Chest Wall Tolerance of Stereotactic Body Radiation Therapy. Semin Radiat Oncol. 2016 Apr; 26(2):129-34. PMID: 27000509.
      View in: PubMed
    26. Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell LK, Parikh SA, Murphy JD. Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer. Int J Radiat Oncol Biol Phys. 2016 Mar 15; 94(4):700-8. PMID: 26972642.
      View in: PubMed
    27. Nuyttens JJ, Moiseenko V, McLaughlin M, Jain S, Herbert S, Grimm J. Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy. Semin Radiat Oncol. 2016 Apr; 26(2):120-8. PMID: 27000508.
      View in: PubMed
    28. Karunamuni R, Bartsch H, White NS, Moiseenko V, Carmona R, Marshall DC, Seibert TM, McDonald CR, Farid N, Krishnan A, Kuperman J, Mell L, Brewer JB, Dale AM, Hattangadi-Gluth JA. Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. Int J Radiat Oncol Biol Phys. 2016 Feb 01; 94(2):297-304. PMID: 26853338.
      View in: PubMed
    29. van Luijk P, Pringle S, Deasy JO, Moiseenko VV, Faber H, Hovan A, Baanstra M, van der Laan HP, Kierkels RG, van der Schaaf A, Witjes MJ, Schippers JM, Brandenburg S, Langendijk JA, Wu J, Coppes RP. Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer. Sci Transl Med. 2015 Sep 16; 7(305):305ra147. PMID: 26378247; PMCID: PMC4964284.
    30. Clark HD, Moiseenko VV, Rackley TP, Thomas SD, Wu JS, Reinsberg SA. Development of a method for functional aspect identification in parotid using dynamic contrast-enhanced magnetic resonance imaging and concurrent stimulation. Acta Oncol. 2015; 54(9):1686-90. PMID: 26252349.
      View in: PubMed
    31. Casares-Magaz O, Thor M, Liao D, Frøkjær JB, Kræmer P, Krogh K, Drewes AM, Gregersen H, Moiseenko V, Høyer M, Muren LP. An image-based method to quantify biomechanical properties of the rectum in radiotherapy of prostate cancer. Acta Oncol. 2015; 54(9):1335-42. PMID: 26198656.
      View in: PubMed
    32. Moore KL, Schmidt R, Moiseenko V, Olsen LA, Tan J, Xiao Y, Galvin J, Pugh S, Seider MJ, Dicker AP, Bosch W, Michalski J, Mutic S. Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):228-35. PMID: 25847605; PMCID: PMC4431941.
    33. Clark H, Hovan A, Moiseenko V, Thomas S, Wu J, Reinsberg S. Regional radiation dose susceptibility within the parotid gland: effects on salivary loss and recovery. Med Phys. 2015 Apr; 42(4):2064-71. PMID: 25832096.
      View in: PubMed
    34. Xu B, Boero IJ, Hwang L, Le QT, Moiseenko V, Sanghvi PR, Cohen EE, Mell LK, Murphy JD. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 2015 Apr 15; 121(8):1303-11. PMID: 25537836; PMCID: PMC4774546.
    35. Sonier M, Gete E, Herbert C, McKenzie M, Murphy J, Moiseenko V. Intensity-modulated stereotactic radiosurgery for arteriovenous malformations: guidance for treatment planning. Radiat Oncol. 2014 Mar 10; 9:73. PMID: 24612667; PMCID: PMC3995862.
    36. Murphy JD, Hattangadi-Gluth J, Song WY, Vollans E, Camborde ML, Kosztyla R, Loewen SK, Crumley C, Moiseenko V. Liver toxicity prediction with stereotactic body radiation therapy: The impact of accounting for fraction size. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):372-7. PMID: 25407857.
      View in: PubMed
    37. Moore KL, Kagadis GC, McNutt TR, Moiseenko V, Mutic S. Vision 20/20: Automation and advanced computing in clinical radiation oncology. Med Phys. 2014 Jan; 41(1):010901. PMID: 24387492.
      View in: PubMed
    38. Thor M, Apte A, Deasy JO, Karlsdóttir À, Moiseenko V, Liu M, Muren LP. Dose/volume-response relations for rectal morbidity using planned and simulated motion-inclusive dose distributions. Radiother Oncol. 2013 Dec; 109(3):388-93. PMID: 24231236; PMCID: PMC4765373.
    39. Kosztyla R, Chan EK, Hsu F, Wilson D, Ma R, Cheung A, Zhang S, Moiseenko V, Benard F, Nichol A. High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers. Int J Radiat Oncol Biol Phys. 2013 Dec 01; 87(5):1100-6. PMID: 24161427.
      View in: PubMed
    40. Lee R, Chan EK, Kosztyla R, Liu M, Moiseenko V. Dose-distance metric that predicts late rectal bleeding in patients receiving radical prostate external-beam radiotherapy. Phys Med Biol. 2012 Dec 21; 57(24):8297-307. PMID: 23190583.
      View in: PubMed
    41. Qiu Y, Moiseenko V, Aquino-Parsons C, Duzenli C. Equivalent doses for gynecological patients undergoing IMRT or RapidArc with kilovoltage cone beam CT. Radiother Oncol. 2012 Aug; 104(2):257-62. PMID: 22857803.
      View in: PubMed
    42. Simpson DR, Song WY, Moiseenko V, Rose BS, Yashar CM, Mundt AJ, Mell LK. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):e81-6. PMID: 22516388.
      View in: PubMed
    43. Moiseenko V, Lapointe V, James K, Yin L, Liu M, Pawlicki T. Biological consequences of MLC calibration errors in IMRT delivery and QA. Med Phys. 2012 Apr; 39(4):1917-24. PMID: 22482613.
      View in: PubMed
    44. Allen Li X, Alber M, Deasy JO, Jackson A, Ken Jee KW, Marks LB, Martel MK, Mayo C, Moiseenko V, Nahum AE, Niemierko A, Semenenko VA, Yorke ED. The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys. 2012 Mar; 39(3):1386-409. PMID: 22380372.
      View in: PubMed
    45. Kosztyla R, Olson R, Carolan H, Balkwill S, Moiseenko V, Kwan W. Evaluation of dosimetric consequences of seroma contour variability in accelerated partial breast irradiation using a constructed representative seroma contour. Int J Radiat Oncol Biol Phys. 2012 Oct 01; 84(2):527-32. PMID: 22342091.
      View in: PubMed
    46. Herbert C, Moiseenko V, McKenzie M, Redekop G, Hsu F, Gete E, Gill B, Lee R, Luchka K, Haw C, Lee A, Toyota B, Martin M. Factors predictive of symptomatic radiation injury after linear accelerator-based stereotactic radiosurgery for intracerebral arteriovenous malformations. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):872-7. PMID: 22208972.
      View in: PubMed
    47. Herbert C, Liu M, Tyldesley S, Morris WJ, Joffres M, Khaira M, Kwan W, Moiseenko V, Pickles T. Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90%. Int J Radiat Oncol Biol Phys. 2012 May 01; 83(1):22-7. PMID: 22079724.
      View in: PubMed
    48. Bhandare N, Moiseenko V, Song WY, Morris CG, Bhatti MT, Mendenhall WM. Severe dry eye syndrome after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys. 2012 Mar 15; 82(4):1501-8. PMID: 21764525.
      View in: PubMed
    49. Moiseenko V, Song WY, Mell LK, Bhandare N. A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy. Radiat Oncol. 2011 Jun 06; 6:61. PMID: 21645390; PMCID: PMC3127783.
    50. Moiseenko V, Wu J, Hovan A, Saleh Z, Apte A, Deasy JO, Harrow S, Rabuka C, Muggli A, Thompson A. Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1108-14. PMID: 21640505; PMCID: PMC3192313.
    51. Shaffer R, Vollans E, Vellani R, Welsh M, Moiseenko V, Goddard K. A radiotherapy planning study of RapidArc, intensity modulated radiotherapy, three-dimensional conformal radiotherapy, and parallel opposed beams in the treatment of pediatric retroperitoneal tumors. Pediatr Blood Cancer. 2011 Jan; 56(1):16-23. PMID: 20949587.
      View in: PubMed
    52. Liu M, Moiseenko V, Agranovich A, Karvat A, Kwan W, Saleh ZH, Apte AA, Deasy JO. Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model. Acta Oncol. 2010 Oct; 49(7):1040-4. PMID: 20831493; PMCID: PMC4786007.
    53. Shaffer R, Pickles T, Lee R, Moiseenko V. Deriving prostate alpha-beta ratio using carefully matched groups, long follow-up and the phoenix definition of biochemical failure. Int J Radiat Oncol Biol Phys. 2011 Mar 15; 79(4):1029-36. PMID: 20558012.
      View in: PubMed
    54. Yin L, Shcherbinin S, Celler A, Thompson A, Fua TF, Liu M, Duzenli C, Gill B, Sheehan F, Powe J, Worsley D, Marks L, Moiseenko V. Incorporating quantitative single photon emission computed tomography into radiation therapy treatment planning for lung cancer: impact of attenuation and scatter correction on the single photon emission computed tomography-weighted mean dose and functional lung segmentation. Int J Radiat Oncol Biol Phys. 2010 Oct 01; 78(2):587-94. PMID: 20452138.
      View in: PubMed
    55. Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S58-63. PMID: 20171519; PMCID: PMC4041494.
    56. Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, Marks LB. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3 Suppl):S77-85. PMID: 20171522.
      View in: PubMed
    57. Shaffer R, Nichol AM, Vollans E, Fong M, Nakano S, Moiseenko V, Schmuland M, Ma R, McKenzie M, Otto K. A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. Int J Radiat Oncol Biol Phys. 2010 Mar 15; 76(4):1177-84. PMID: 19560880.
      View in: PubMed
    58. Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, McKenzie M, Morris J, Otto K. Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2008 Nov 15; 72(4):996-1001. PMID: 18455326.
      View in: PubMed
    59. Moiseenko V, Duzenli C, Durand RE. In vitro study of cell survival following dynamic MLC intensity-modulated radiation therapy dose delivery. Med Phys. 2007 Apr; 34(4):1514-20. PMID: 17500482.
      View in: PubMed
    60. Zhang M, Moiseenko V, Liu M. PTV margin for dose escalated radiation therapy of prostate cancer with daily on-line realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysis. J Appl Clin Med Phys. 2006 May 25; 7(2):38-49. PMID: 17533327.
      View in: PubMed
    61. Moiseenko V, Liu M, Kristensen S, Gelowitz G, Berthelet E. Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study. J Appl Clin Med Phys. 2006 Apr 12; 8(1):55-68. PMID: 17592448.
      View in: PubMed
    62. Moiseenko V. Effect of heterogeneity in radiosensitivity on LQ based isoeffect formalism for low alpha/beta cancers. Acta Oncol. 2004; 43(5):499-502. PMID: 15360056.
      View in: PubMed
    63. Craig T, Moiseenko V, Battista J, Van Dyk J. The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Nov 01; 57(3):833-42. PMID: 14529791.
      View in: PubMed
    64. Moiseenko V, Craig T, Bezjak A, Van Dyk J. Dose-volume analysis of lung complications in the radiation treatment of malignant thymoma: a retrospective review. Radiother Oncol. 2003 Jun; 67(3):265-74. PMID: 12865174.
      View in: PubMed